Advertisement

pp 1-14 | Cite as

Potential of Tribological Properties of Metal Nanomaterials in Biomedical Applications

  • Pravin ShendeEmail author
  • Drashti Patel
Chapter
Part of the Advances in Experimental Medicine and Biology book series

Abstract

Metallic nanomaterials show tremendous applications in biomedical devices due to compatible integration into the most of the biological systems as they are nano- structured. Metallic nanomaterials are capable of mimicking all the three major antioxidant enzymes such as catalase (CAT), peroxidase and oxidase, to control the level of reactive oxygen species (ROS) inside the cell as an alternative strategy over conventional one which has biological toxicity and have several adverse effects, if accumulation takes places during the treatment. This anti-oxidant property of metallic nanomaterials demonstrates as a promising candidate for its biomedical application in disease conditions where the excessive level of ROS causes damage to DNA, lipids and protein in several conditions such as diabetes, cancer and neurodegenerative diseases. Tribology is the study of interacting surfaces in motion and the measurement of properties such as friction, wear-tear and abrasion. While designing nano-scale biomedical devices, the consideration of tribology is particularly important because the high surface area ratio enhances problems with friction and wear-tear which can further affects its function as well as longevity.

Graphical Abstract

Keywords

Biomedical application Metallic nanomaterial Tribological testing Tribology 

Abbreviations

AD

Alzheimer’s disease

Amyloid beta

CAT

Catalase

CLP

Regulation concerning Classification, Labeling and Packaging of Substances and Mixtures

EGF

Epidermal growth factor

FGH

fibroblast growth factor

LSPR

Large Surface Area Plasmon resonance

Mn3O4

Manganese oxide

PBCA-Ti/Au

Polybutylcyanoacrylate polymer-Titanium/Aluminum

PDGF

Platelet-derived growth factor

REACH

Registration, Evaluation, Authorization and Restrictions of Chemicals

ROS

Reactive oxygen species

SERs

Surface-enhanced Raman Scattering

SNC

Substantial Nigra pars Compacta

SNURs

Significant New Use Rules

TSCA

Toxic Substance Control Act

VEGF

Vascular endothelial growth factor

References

  1. Adhikary RR, Sandbhor P, Banerjee R (2015) Nanotechnology platforms in Parkinson’s disease. ADMET DMPK 3:155–181Google Scholar
  2. Ahmad J, Akhter S, Khan MA (2018) Nanotechnology based Theranostic approaches in Alzheimer’s disease management: current status and future perspective. Curr Alzheimer Res 14:1164–1181Google Scholar
  3. Alistair C, Morris ER, Horcajada P, Ferey G, Gref R, Couvreur P, Serre C (2010) BioMOFs: metal–organic frameworks for biological and medical applications. Angew Chem 49:6260–6266Google Scholar
  4. Al-fartusie FS, Mohssan SN (2017) Essential trace elements and their vital roles in human body. Indian J Adv Chem Sci:127–136.  https://doi.org/10.22607/IJACS.2017.503003
  5. Atom C, Metal N, Corma A, Kumar D (1999) Learn more about metal catalyst adsorption and its applications in industry and environmental protection mesoporous molecular sieves 1998Google Scholar
  6. Bakalova T, Voleský L, Škodová P, Louda (2014) Effect of natural fillers in the form of nanoparticles on the tribological properties of process fluids. Nano 5–10Google Scholar
  7. Baptista P (2012) Noble metal nanoparticles applications in cancer. J Drug Deliv 2012:1–13Google Scholar
  8. Buzea C, Pacheco II, Robbie K (2017) Nanomaterials and nanoparticles: sources and toxicity. Biointerphases 2:1–57.  https://doi.org/10.1116/1.2815690CrossRefGoogle Scholar
  9. Cassano D, Voliani V (2018) Ultrasmall-in-nano approach: enabling the translation of metal nanomaterials to clinics. Bioconjug Chem 29(1):4–16.  https://doi.org/10.1021/acs.bioconjchem.7b00664CrossRefGoogle Scholar
  10. Chaudhri N, Soni GC, Prajapati SK (2015) Nanotechnology: an advance tool for nano-cosmetics preparation. Int J Pharma Res Rev 4:28–40Google Scholar
  11. Chen PC, Mwakwari SC, Oyelere AK (2008) Gold nanoparticles: from nanomedicine to nanosensing. Nanotechnol Sci Appl 1:45–66Google Scholar
  12. Chowdhury A, Kunjiappan S, Panneerselvam T, Somasundaram B, Bhattacharjee C (2017) Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases. Int Nano Lett 7:91–122Google Scholar
  13. Contado C (2015) Nanomaterials in consumer products: a challenging analytical problem. Front Chem 3:1–20Google Scholar
  14. Credits I, Artem E (2017) Tribology for nanotechnology applications nanotechnology applications of tribology for biosensors and drug delivery nanotechnology applications of tribology for data storage. Azo Nano, AZoNetwork UK Ltd, UK, pp 1–3Google Scholar
  15. Disanto RM, Subramanian V, Gu Z (2018) Recent advances in nanotechnology for diabetes treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:1–24Google Scholar
  16. Friedrich K (2018) Advanced industrial and engineering polymer research polymer composites for tribological applications. Adv Ind Eng Polymer Res 1:3–39Google Scholar
  17. Harish Kumar K, Venkatesh N, Bhowmik H, Kuila A (2018) Metallic nanoparticle: a review. Biomed J Sci Tech Res 4(2):3765–3775.  https://doi.org/10.26717/BJSTR.2018.04.001011CrossRefGoogle Scholar
  18. Harish KK, Nagasamy V, Himangshu B, Anuttam K (2018) Metallic nanoparticle: a review. Biomed J Sci Tech Res 4:1–11Google Scholar
  19. Jacques CV (2017) Heterogeneous catalysis on metal oxides. Catalysts 7:1–25.  https://doi.org/10.3390/catal7110341CrossRefGoogle Scholar
  20. Jinga V et al (2016) The influence of nanoadditives on the tribological properties of process fluids. J Phys Conf Ser:1–11.  https://doi.org/10.1088/1742-6596/709/1/012001
  21. Karthivashan G, Ganesan P, Park S, Choi D (2018) Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease. Drug Deliv 0:307–320Google Scholar
  22. Katz LM (2007) Nanotechnology and applications in cosmetics: general overview. ACS Symp Ser:193–200.  https://doi.org/10.1021/bk-2007-0961.ch011
  23. Kaushik AC, Bharadwaj S, Kumar S, Wei D (2018) Nano-particle mediated inhibition of Parkinson’s disease using computational biology approach. Sci Rep:1–8.  https://doi.org/10.1038/s41598-018-27580-1
  24. Leszek J, Ashraf G, Tse WH, Zhang J, Kazimierz G (2017) Nanotechnology for Alzheimer disease. Curr Alzheimer Res 14(11):1182–1118.  https://doi.org/10.2174/15672050146661702031CrossRefGoogle Scholar
  25. Lushchak O, Zayachkivska A, Vaiserman A (2018) Metal846 lic nanoantioxidants as potential therapeutics for type 847 2 diabetes: a hypothetical background and translational AU6 848 perspectives. Oxidative Med Cell Longev 1–9Google Scholar
  26. Mody VV, Siwale R, Singh A, Mody HR (2010) Introduction to metallic nanoparticles. J Pharm Bioallied Sci 2:282–289Google Scholar
  27. Montaño MD, Ranville J (2014) Detection and characterization of engineered nanomaterials in the environment: current state-of-the-art and future directions. U.S. Environmental Protection Agency, Washington, DCGoogle Scholar
  28. My T, Dang D, Tuyet T, Le T, Fribourg-blanc E (2011) Synthesis and optical properties of copper nanoparticles prepared by a chemical reduction process. Adv Nat Sci Nanosci Nanotechnol:1–7.  https://doi.org/10.1088/2043-6262/2/1/015009
  29. Ndagi U, Mhlongo N, Soliman ME (2017) Metal complexes in cancer therapy – an update from drug design perspective. Drug Des Devel Ther 11:599–616Google Scholar
  30. Nikalje AP (2015) Nanotechnology and its applications in medicine. Med Chem 5(2):81–89.  https://doi.org/10.4172/2161-0444.1000247CrossRefGoogle Scholar
  31. Noraihan T, Tuan A, Mohamad D, Ismail AR (2011) Synthesis of nanosilica fillers for experimental dental nanocomposites and their characterisations. J Phys Sci 22:93–105Google Scholar
  32. Osredkar J, Sustar N (2011) Copper and zinc, biological role and significance of copper/zinc imbalance. J Clin Toxicol:1–18.  https://doi.org/10.4172/2161-0495.S3-001
  33. Park Y (2012) Nano-regulation in China, Japan, Korea, USA and EU. http://www.egg2012.De/tl_files/pdf/paper/EGG2012
  34. Press D (2017) Metal complexes in cancer therapy – an update from drug design perspective. Drug Des Devel Ther 11:599–616Google Scholar
  35. Radomska A, Leszczyszyn J, Radomski M (2016) The nanopharmacology and nanotoxicology of nanomaterials: new opportunities and challenges. Adv Clin Exp Med 25:151–162.  https://doi.org/10.17219/acem/60879CrossRefGoogle Scholar
  36. Rafique S, Idrees M, Nasim A, Akbar H, Athar A (2010) Transition metal complexes as potential therapeutic agents. Biotechnol Mol Biol Rev 5:38–45Google Scholar
  37. Raj S, Sumod U, Jose S, Sabitha M (2012) Nanotechnology in cosmetics: opportunities and challenges. J Pharm Bioallied Sci 4:186–193Google Scholar
  38. Rasmussen K et al (2018) Physico-chemical properties of manufactured nanomaterials – characterisation and relevant methods. An outlook based on the OECD testing Programme. Regul Toxicol Pharmacol 92:8–28Google Scholar
  39. Santos CL, Albuquerque AJR, Sampaio FC, Keyson D (2013) Nanomaterials with antimicrobial properties: applications in health sciences. In: Méndez-Vilas A (ed) Microbial pathogens and strategies for combating them: science, technology and education, 1st edn. Formatex Research Center, Badajoz, pp 143–154Google Scholar
  40. Shende P, Basarkar V (2019) Recent trends and advances in microbe-based drug delivery systems. DARU J Pharm Sci.  https://doi.org/10.1007/s40199-019-00291-2
  41. Siddiqi KS, Husen A, Sohrab SS, Yassin MO (2018) Recent status of nanomaterial fabrication and their potential applications in neurological disease management. Nanoscale Res Lett 13(15–18)Google Scholar
  42. Thirumalaikumaran A (2017) The tribological behaviour of nanoparticles mixed lubricating oil – review. Int Res J Eng Technol 4:3220–3228Google Scholar
  43. Valavanidis A, Vlachogianni T (2016) Engineered nanomaterials for pharmaceutical and biomedical products new trends, benefits and opportunities. Pharm Bioprocess 4(1):13–24Google Scholar
  44. Vimbela GV, Ngo SM, Fraze C, Yang L, Stout DA (2017) Antibacterial properties and toxicity from metallic nanomaterials. Int J Nanomedicine 12:3941–3965Google Scholar
  45. Woldu MA, Lenjisa JL (2014) Nanoparticles and the new era in diabetes management. Int J Basic Clin Pharmacol 3:277–284Google Scholar
  46. Yang L, Liu H, Lin Y (2015) Biomaterial nanotopography-mediated cell responses: experiment and modeling. Int J Smart Nano Mater 5:227–256Google Scholar
  47. Yapar EA, Inal O (2012) Nanomaterials and cosmetics. J Pharm Istanbul Univ 42(1):43–70Google Scholar
  48. Yeung KWK (2010) Nanotechnology in biomedical applications: a review. Int J Nano Biomater 3(2):119–132.  https://doi.org/10.1504/IJNBM.2010.037801CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Shobhaben Pratapbhai Patel School of Pharmacy and Technology ManagementSVKM’S NMIMSMumbaiIndia

Personalised recommendations